# Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,

> **NCT04873115** · PHASE4 · UNKNOWN · sponsor: **Proveca Pharma Limited** · enrollment: 80 (estimated)

## Conditions studied

- Sialorrhea
- Neurodevelopmental Disorders

## Interventions

- **OTHER:** Placebo
- **DRUG:** Sialanar
- **OTHER:** Oral Rehabilitation

## Key facts

- **NCT ID:** NCT04873115
- **Lead sponsor:** Proveca Pharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-10
- **Primary completion:** 2022-12-10
- **Final completion:** 2023-06-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873115, "Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04873115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*